Trials / Completed
CompletedNCT01176253
Detection of Human Beta Cell Death in Type 1 Diabetes Mellitus (T1DM) by Methylation Specific Polymerase Chain Reaction (PCR)
Detection of Human Beta Cell Death in T1DM by Methylation Specific PCR
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 6 (actual)
- Sponsor
- City of Hope Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
To investigate the use of methylation-specific PCR (MSP) assays to detect human beta cell-specific gene methylation patterns in serial blood samples drawn from newly diagnosed Type 1 diabetics.
Detailed description
The study will follow 25 newly diagnosed type 1 diabetic patients from the onset of symptoms to one year post-diagnosis. A total of 11 fasting blood draws will be taken, the first near the time of diabetes diagnosis, then 2 weeks later, monthly for the next 6 months, and every other month until 12 months. Each blood sample will be evaluated by the MSP assay, as well as for measurement of fasting plasma glucose, HbA1c, c-peptide, and autoantibodies. The study will also need 25 healthy volunteers to help us match some DNA markers needed for this data. Healthy volunteers will be se=matched healthy individuals who have one blood sample drawn.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Blood draw | Blood draw for Type I DM patients will be taken every 4 weeks for 1 year post diagnosis/healthy volunteers will have 1 blood draw |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2015-04-01
- Completion
- 2015-04-01
- First posted
- 2010-08-05
- Last updated
- 2015-05-01
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01176253. Inclusion in this directory is not an endorsement.